In mounting woes for Monsanto, Competition Commission has ordered another detailed probe against the genetically-modified seed major for alleged unfair business practices.
This is the third time this year that CCI is ordering a probe against the company and the latest one is based on a complaint filed by Hyderabad-based Amar Biotech pertaining to Sub-Licensing Agreement (SLA).
The latest complaint was filed against Mahyco Monsanto Biotech (India) Ltd, Monsanto Holdings Pvt Ltd, Monsanto Company and Maharashtra Hybrid Seeds Company Ltd.
Ordering the probe, Competition Commission of India (CCI) said that in the present case, “the SLA was not extended/ renewed by Opposite Party 1 (Mahyco Monsanto Biotech) after efflux of time”.
Full Content: Financial Express
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
FTC Withdraws Case Against Microsoft-Activision Merger, Citing Public Interest
May 23, 2025 by
CPI
Charter to Acquire Cox Communications in $35 Billion Deal
May 22, 2025 by
CPI
FTC Targets Media Watchdog Over Alleged Collusion Against Musk’s X
May 22, 2025 by
CPI
FTC Drops Antitrust Case Accusing Pepsi of Squeezing Small Retailers
May 22, 2025 by
CPI
Shein Warns of Higher Costs for French Shoppers Amid EU Fee Proposal
May 22, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Industrial Policy
May 21, 2025 by
CPI
Industrial Strategy and the Role of Competition – Taking a Business Lens
May 21, 2025 by
Marcus Bokkerink
Industrial Policy, Antitrust, and Economic Growth: Some Observations
May 21, 2025 by
David S. Evans
Bolder by Design: Crafting Pro-Competitive Industrial Policies For Complex Challenges
May 21, 2025 by
Antonio Capobianco & Beatriz Marques
Competition-Friendly Industrial Policy
May 21, 2025 by
Philippe Aghion, Mathias Dewatripont & Patrick Legros